Electroconvulsive therapy for depression is more effective and associated with fewer adverse effects in the patients aged 85 years or older than in younger patients, research shows.

The FDA has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder.

Send comments and news tips to news@medscape.net. Cite this: Parent-Child Therapy Works for Depression in Young Children, Has Long-lasting Effects, Study Shows - Medscape - July 03, 2025.

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of treatment-resistant depression in a mid-stage trial.

Depression affects 1%-2% of children younger than 13 in the U.S. and can arise as early as age 3, but a specialized therapeutic intervention can help preschool-aged children find relief from this ...

Early research has suggested psilocybin, the active ingredient in magic mushrooms, may be effective at treating clinical depression and PTSD. Now, it is being studied as a potential new therapy ...

Sangamo's investigational gene therapy has been tied to an improvement in kidney health deterioration at 52 weeks for patients with Fabry disease.

Compass points to psychedelic therapy's phase 3 depression win, but investors unimpressed By James Waldron Jun 23, 2025 8:05am Compass Pathways psychedelic drug psilocybin treatment-resistant ...

Compass Pathways said Monday it achieved its primary endpoint in an early readout from the largest-ever study of psilocybin for treatment-resistant depression.

A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations ...

A number of companies are building A.I. apps for patients to talk to when human therapists aren’t available.

Testosterone Therapy Is Booming. But Is It Actually Safe? As more men turn to testosterone replacement therapy (TRT) for energy, mood and muscle, experts warn the risks are still not fully understood.